331 related articles for article (PubMed ID: 37373381)
1. Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT).
Dorta-Gorrín A; Navas-Méndez J; Gozalo-Margüello M; Miralles L; García-Hevia L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373381
[TBL] [Abstract][Full Text] [Related]
2. Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example.
Kang T; Lu J; Yu T; Long Y; Liu G
Biosens Bioelectron; 2022 Jun; 206():114109. PubMed ID: 35245867
[TBL] [Abstract][Full Text] [Related]
3. Point of care molecular and antigen detection tests for COVID-19: current status and future prospects.
Stokes W; Berenger BM; Venner AA; Deslandes V; Shaw JLV
Expert Rev Mol Diagn; 2022 Aug; 22(8):797-809. PubMed ID: 36093682
[TBL] [Abstract][Full Text] [Related]
4. Lab-on-a-Disc for Point-of-Care Infection Diagnostics.
Sunkara V; Kumar S; Sabaté Del Río J; Kim I; Cho YK
Acc Chem Res; 2021 Oct; 54(19):3643-3655. PubMed ID: 34516092
[TBL] [Abstract][Full Text] [Related]
5. Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests.
Payne D; Williams C; Jacob J; Chastain-Potts S; Adjei M; Taye B; Montalvo S; Short L; Tran A
J Clin Microbiol; 2023 Jul; 61(7):e0041323. PubMed ID: 37395672
[TBL] [Abstract][Full Text] [Related]
6. A sample-to-answer, quantitative real-time PCR system with low-cost, gravity-driven microfluidic cartridge for rapid detection of SARS-CoV-2, influenza A/B, and human papillomavirus 16/18.
Zai Y; Min C; Wang Z; Ding Y; Zhao H; Su E; He N
Lab Chip; 2022 Sep; 22(18):3436-3452. PubMed ID: 35972195
[TBL] [Abstract][Full Text] [Related]
7. Recent advances and clinical application in point-of-care testing of SARS-CoV-2.
Ye Q; Lu D; Zhang T; Mao J; Shang S
J Med Virol; 2022 May; 94(5):1866-1875. PubMed ID: 35080017
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test.
Katzman BM; Wockenfus AM; Kelley BR; Karon BS; Donato LJ
Clin Biochem; 2023 Jul; 117():1-3. PubMed ID: 34798145
[TBL] [Abstract][Full Text] [Related]
9. iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
Ali Z; Aman R; Mahas A; Rao GS; Tehseen M; Marsic T; Salunke R; Subudhi AK; Hala SM; Hamdan SM; Pain A; Alofi FS; Alsomali A; Hashem AM; Khogeer A; Almontashiri NAM; Abedalthagafi M; Hassan N; Mahfouz MM
Virus Res; 2020 Oct; 288():198129. PubMed ID: 32822689
[TBL] [Abstract][Full Text] [Related]
10. Automated sample-to-answer centrifugal microfluidic system for rapid molecular diagnostics of SARS-CoV-2.
Malic L; Brassard D; Da Fonte D; Nassif C; Mounier M; Ponton A; Geissler M; Shiu M; Morton KJ; Veres T
Lab Chip; 2022 Aug; 22(17):3157-3171. PubMed ID: 35670202
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Point-of-Care (POC) Diagnosis Based on Commercial Pregnancy Test Strips and a Palm-Size Microfluidic Device.
Yang M; Tang Y; Qi L; Zhang S; Liu Y; Lu B; Yu J; Zhu K; Li B; Du Y
Anal Chem; 2021 Sep; 93(35):11956-11964. PubMed ID: 34424659
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs).
Kohmer N; Rabenau HF; Hoehl S; Kortenbusch M; Ciesek S; Berger A
J Virol Methods; 2021 May; 291():114102. PubMed ID: 33607117
[TBL] [Abstract][Full Text] [Related]
13. A precise review on NAATs-based diagnostic assays for COVID-19: A motion in fast POC molecular tests.
Maleki B; Hojati Z
Eur J Clin Invest; 2022 Nov; 52(11):e13853. PubMed ID: 35989561
[TBL] [Abstract][Full Text] [Related]
14. Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests.
Delgado-Diaz DJ; Sakthivel D; Nguyen HHT; Farrokzhad K; Hopper W; Narh CA; Richards JS
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746782
[TBL] [Abstract][Full Text] [Related]
15. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches for rapid detection of COVID-19 during the pandemic: A review.
Ilkhani H; Hedayat N; Farhad S
Anal Biochem; 2021 Dec; 634():114362. PubMed ID: 34478703
[TBL] [Abstract][Full Text] [Related]
17. Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution.
Kumar A; Parihar A; Panda U; Parihar DS
ACS Appl Bio Mater; 2022 May; 5(5):2046-2068. PubMed ID: 35473316
[TBL] [Abstract][Full Text] [Related]
18. A rapid diagnosis of SARS-CoV-2 using DNA hydrogel formation on microfluidic pores.
Kim HS; Abbas N; Shin S
Biosens Bioelectron; 2021 Apr; 177():113005. PubMed ID: 33486135
[TBL] [Abstract][Full Text] [Related]
19. Palm-Sized Lab-In-A-Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection.
Li Z; Zhang S; Zhang J; Avery L; Banach D; Zhao H; Liu C
Adv Sci (Weinh); 2024 Jun; 11(23):e2310066. PubMed ID: 38634211
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond.
Vindeirinho JM; Pinho E; Azevedo NF; Almeida C
Front Cell Infect Microbiol; 2022; 12():799678. PubMed ID: 35402302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
